SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-23-265664
Filing Date
2023-10-30
Accepted
2023-10-30 07:24:27
Documents
1

Document Format Files

Seq Description Document Type Size
1 DEFA14A d524734ddefa14a.htm DEFA14A 43315
  Complete submission text file 0001193125-23-265664.txt   44636
Mailing Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 356 NEWTON MA 02458
Business Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 356 NEWTON MA 02458 (844) 902-6100
Acer Therapeutics Inc. (Filer) CIK: 0001069308 (see all company filings)

IRS No.: 320426967 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33004 | Film No.: 231357195
SIC: 2834 Pharmaceutical Preparations